Global Perfluorocarbon-based Ultrasound Contrast Agents Market Growth 2026-2032
The global Perfluorocarbon-based Ultrasound Contrast Agents market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
Perfluorocarbon-based ultrasound contrast agents are special types of ultrasound contrast agents. These contrast agents use perfluorocarbons as the gas filler within the microbubbles, and due to their good stability and biocompatibility, they have been widely used in medical imaging fields.
United States market for Perfluorocarbon-based Ultrasound Contrast Agents is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Perfluorocarbon-based Ultrasound Contrast Agents is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Perfluorocarbon-based Ultrasound Contrast Agents is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Perfluorocarbon-based Ultrasound Contrast Agents players cover Bracco, GE Healthcare, Lantheus Medical Imaging, ImaRx Therapeutics, Microvascular Therapeutics, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Perfluorocarbon-based Ultrasound Contrast Agents Industry Forecast? looks at past sales and reviews total world Perfluorocarbon-based Ultrasound Contrast Agents sales in 2025, providing a comprehensive analysis by region and market sector of projected Perfluorocarbon-based Ultrasound Contrast Agents sales for 2026 through 2032. With Perfluorocarbon-based Ultrasound Contrast Agents sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Perfluorocarbon-based Ultrasound Contrast Agents industry.
This Insight Report provides a comprehensive analysis of the global Perfluorocarbon-based Ultrasound Contrast Agents landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Perfluorocarbon-based Ultrasound Contrast Agents portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Perfluorocarbon-based Ultrasound Contrast Agents market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Perfluorocarbon-based Ultrasound Contrast Agents and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Perfluorocarbon-based Ultrasound Contrast Agents.
This report presents a comprehensive overview, market shares, and growth opportunities of Perfluorocarbon-based Ultrasound Contrast Agents market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Perfluorocarbon-based Ultrasound Contrast Agents market?
What factors are driving Perfluorocarbon-based Ultrasound Contrast Agents market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Perfluorocarbon-based Ultrasound Contrast Agents market opportunities vary by end market size?
How does Perfluorocarbon-based Ultrasound Contrast Agents break out by Type, by Application?
Perfluorocarbon-based ultrasound contrast agents are special types of ultrasound contrast agents. These contrast agents use perfluorocarbons as the gas filler within the microbubbles, and due to their good stability and biocompatibility, they have been widely used in medical imaging fields.
United States market for Perfluorocarbon-based Ultrasound Contrast Agents is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Perfluorocarbon-based Ultrasound Contrast Agents is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Perfluorocarbon-based Ultrasound Contrast Agents is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Perfluorocarbon-based Ultrasound Contrast Agents players cover Bracco, GE Healthcare, Lantheus Medical Imaging, ImaRx Therapeutics, Microvascular Therapeutics, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Perfluorocarbon-based Ultrasound Contrast Agents Industry Forecast? looks at past sales and reviews total world Perfluorocarbon-based Ultrasound Contrast Agents sales in 2025, providing a comprehensive analysis by region and market sector of projected Perfluorocarbon-based Ultrasound Contrast Agents sales for 2026 through 2032. With Perfluorocarbon-based Ultrasound Contrast Agents sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Perfluorocarbon-based Ultrasound Contrast Agents industry.
This Insight Report provides a comprehensive analysis of the global Perfluorocarbon-based Ultrasound Contrast Agents landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Perfluorocarbon-based Ultrasound Contrast Agents portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Perfluorocarbon-based Ultrasound Contrast Agents market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Perfluorocarbon-based Ultrasound Contrast Agents and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Perfluorocarbon-based Ultrasound Contrast Agents.
This report presents a comprehensive overview, market shares, and growth opportunities of Perfluorocarbon-based Ultrasound Contrast Agents market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Sulfur Hexafluoride
- Perfluoropropane
- Perfluorobutane
- Others
- Liver Ultrasonography
- Angiographic Ultrasonography
- Cardiac Ultrasonography
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Bracco
- GE Healthcare
- Lantheus Medical Imaging
- ImaRx Therapeutics
- Microvascular Therapeutics
- Qi-hui Biopharmaceutical
- Feiruida Medical
- SUN? Med-Engineering
- Lizhuo Pharmaceutical
- Fuman Group
What is the 10-year outlook for the global Perfluorocarbon-based Ultrasound Contrast Agents market?
What factors are driving Perfluorocarbon-based Ultrasound Contrast Agents market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Perfluorocarbon-based Ultrasound Contrast Agents market opportunities vary by end market size?
How does Perfluorocarbon-based Ultrasound Contrast Agents break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Perfluorocarbon-based Ultrasound Contrast Agents Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Perfluorocarbon-based Ultrasound Contrast Agents by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Perfluorocarbon-based Ultrasound Contrast Agents by Country/Region, 2021, 2025 & 2032
2.2 Perfluorocarbon-based Ultrasound Contrast Agents Segment by Type
2.2.1 Sulfur Hexafluoride
2.2.2 Perfluoropropane
2.2.3 Perfluorobutane
2.2.4 Others
2.2.5 Perfluorocarbon-based Ultrasound Contrast Agents Sales by Type
2.2.5.1 Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Market Share by Type (2021-2026)
2.2.5.2 Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue and Market Share by Type (2021-2026)
2.2.5.3 Global Perfluorocarbon-based Ultrasound Contrast Agents Sale Price by Type (2021-2026)
2.3 Perfluorocarbon-based Ultrasound Contrast Agents Segment by Application
2.3.1 Liver Ultrasonography
2.3.2 Angiographic Ultrasonography
2.3.3 Cardiac Ultrasonography
2.3.4 Others
2.3.5 Perfluorocarbon-based Ultrasound Contrast Agents Sales by Application
2.3.5.1 Global Perfluorocarbon-based Ultrasound Contrast Agents Sale Market Share by Application (2021-2026)
2.3.5.2 Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue and Market Share by Application (2021-2026)
2.3.5.3 Global Perfluorocarbon-based Ultrasound Contrast Agents Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Perfluorocarbon-based Ultrasound Contrast Agents Breakdown Data by Company
3.1.1 Global Perfluorocarbon-based Ultrasound Contrast Agents Annual Sales by Company (2021-2026)
3.1.2 Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Market Share by Company (2021-2026)
3.2 Global Perfluorocarbon-based Ultrasound Contrast Agents Annual Revenue by Company (2021-2026)
3.2.1 Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Company (2021-2026)
3.2.2 Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue Market Share by Company (2021-2026)
3.3 Global Perfluorocarbon-based Ultrasound Contrast Agents Sale Price by Company
3.4 Key Manufacturers Perfluorocarbon-based Ultrasound Contrast Agents Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Perfluorocarbon-based Ultrasound Contrast Agents Product Location Distribution
3.4.2 Players Perfluorocarbon-based Ultrasound Contrast Agents Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS BY GEOGRAPHIC REGION
4.1 World Historic Perfluorocarbon-based Ultrasound Contrast Agents Market Size by Geographic Region (2021-2026)
4.1.1 Global Perfluorocarbon-based Ultrasound Contrast Agents Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Perfluorocarbon-based Ultrasound Contrast Agents Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Perfluorocarbon-based Ultrasound Contrast Agents Market Size by Country/Region (2021-2026)
4.2.1 Global Perfluorocarbon-based Ultrasound Contrast Agents Annual Sales by Country/Region (2021-2026)
4.2.2 Global Perfluorocarbon-based Ultrasound Contrast Agents Annual Revenue by Country/Region (2021-2026)
4.3 Americas Perfluorocarbon-based Ultrasound Contrast Agents Sales Growth
4.4 APAC Perfluorocarbon-based Ultrasound Contrast Agents Sales Growth
4.5 Europe Perfluorocarbon-based Ultrasound Contrast Agents Sales Growth
4.6 Middle East & Africa Perfluorocarbon-based Ultrasound Contrast Agents Sales Growth
5 AMERICAS
5.1 Americas Perfluorocarbon-based Ultrasound Contrast Agents Sales by Country
5.1.1 Americas Perfluorocarbon-based Ultrasound Contrast Agents Sales by Country (2021-2026)
5.1.2 Americas Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Country (2021-2026)
5.2 Americas Perfluorocarbon-based Ultrasound Contrast Agents Sales by Type (2021-2026)
5.3 Americas Perfluorocarbon-based Ultrasound Contrast Agents Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Perfluorocarbon-based Ultrasound Contrast Agents Sales by Region
6.1.1 APAC Perfluorocarbon-based Ultrasound Contrast Agents Sales by Region (2021-2026)
6.1.2 APAC Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Region (2021-2026)
6.2 APAC Perfluorocarbon-based Ultrasound Contrast Agents Sales by Type (2021-2026)
6.3 APAC Perfluorocarbon-based Ultrasound Contrast Agents Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Perfluorocarbon-based Ultrasound Contrast Agents by Country
7.1.1 Europe Perfluorocarbon-based Ultrasound Contrast Agents Sales by Country (2021-2026)
7.1.2 Europe Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Country (2021-2026)
7.2 Europe Perfluorocarbon-based Ultrasound Contrast Agents Sales by Type (2021-2026)
7.3 Europe Perfluorocarbon-based Ultrasound Contrast Agents Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Perfluorocarbon-based Ultrasound Contrast Agents by Country
8.1.1 Middle East & Africa Perfluorocarbon-based Ultrasound Contrast Agents Sales by Country (2021-2026)
8.1.2 Middle East & Africa Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Country (2021-2026)
8.2 Middle East & Africa Perfluorocarbon-based Ultrasound Contrast Agents Sales by Type (2021-2026)
8.3 Middle East & Africa Perfluorocarbon-based Ultrasound Contrast Agents Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Perfluorocarbon-based Ultrasound Contrast Agents
10.3 Manufacturing Process Analysis of Perfluorocarbon-based Ultrasound Contrast Agents
10.4 Industry Chain Structure of Perfluorocarbon-based Ultrasound Contrast Agents
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Perfluorocarbon-based Ultrasound Contrast Agents Distributors
11.3 Perfluorocarbon-based Ultrasound Contrast Agents Customer
12 WORLD FORECAST REVIEW FOR PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS BY GEOGRAPHIC REGION
12.1 Global Perfluorocarbon-based Ultrasound Contrast Agents Market Size Forecast by Region
12.1.1 Global Perfluorocarbon-based Ultrasound Contrast Agents Forecast by Region (2027-2032)
12.1.2 Global Perfluorocarbon-based Ultrasound Contrast Agents Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Perfluorocarbon-based Ultrasound Contrast Agents Forecast by Type (2027-2032)
12.7 Global Perfluorocarbon-based Ultrasound Contrast Agents Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Bracco
13.1.1 Bracco Company Information
13.1.2 Bracco Perfluorocarbon-based Ultrasound Contrast Agents Product Portfolios and Specifications
13.1.3 Bracco Perfluorocarbon-based Ultrasound Contrast Agents Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Bracco Main Business Overview
13.1.5 Bracco Latest Developments
13.2 GE Healthcare
13.2.1 GE Healthcare Company Information
13.2.2 GE Healthcare Perfluorocarbon-based Ultrasound Contrast Agents Product Portfolios and Specifications
13.2.3 GE Healthcare Perfluorocarbon-based Ultrasound Contrast Agents Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 GE Healthcare Main Business Overview
13.2.5 GE Healthcare Latest Developments
13.3 Lantheus Medical Imaging
13.3.1 Lantheus Medical Imaging Company Information
13.3.2 Lantheus Medical Imaging Perfluorocarbon-based Ultrasound Contrast Agents Product Portfolios and Specifications
13.3.3 Lantheus Medical Imaging Perfluorocarbon-based Ultrasound Contrast Agents Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Lantheus Medical Imaging Main Business Overview
13.3.5 Lantheus Medical Imaging Latest Developments
13.4 ImaRx Therapeutics
13.4.1 ImaRx Therapeutics Company Information
13.4.2 ImaRx Therapeutics Perfluorocarbon-based Ultrasound Contrast Agents Product Portfolios and Specifications
13.4.3 ImaRx Therapeutics Perfluorocarbon-based Ultrasound Contrast Agents Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 ImaRx Therapeutics Main Business Overview
13.4.5 ImaRx Therapeutics Latest Developments
13.5 Microvascular Therapeutics
13.5.1 Microvascular Therapeutics Company Information
13.5.2 Microvascular Therapeutics Perfluorocarbon-based Ultrasound Contrast Agents Product Portfolios and Specifications
13.5.3 Microvascular Therapeutics Perfluorocarbon-based Ultrasound Contrast Agents Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Microvascular Therapeutics Main Business Overview
13.5.5 Microvascular Therapeutics Latest Developments
13.6 Qi-hui Biopharmaceutical
13.6.1 Qi-hui Biopharmaceutical Company Information
13.6.2 Qi-hui Biopharmaceutical Perfluorocarbon-based Ultrasound Contrast Agents Product Portfolios and Specifications
13.6.3 Qi-hui Biopharmaceutical Perfluorocarbon-based Ultrasound Contrast Agents Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Qi-hui Biopharmaceutical Main Business Overview
13.6.5 Qi-hui Biopharmaceutical Latest Developments
13.7 Feiruida Medical
13.7.1 Feiruida Medical Company Information
13.7.2 Feiruida Medical Perfluorocarbon-based Ultrasound Contrast Agents Product Portfolios and Specifications
13.7.3 Feiruida Medical Perfluorocarbon-based Ultrasound Contrast Agents Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Feiruida Medical Main Business Overview
13.7.5 Feiruida Medical Latest Developments
13.8 SUN? Med-Engineering
13.8.1 SUN? Med-Engineering Company Information
13.8.2 SUN? Med-Engineering Perfluorocarbon-based Ultrasound Contrast Agents Product Portfolios and Specifications
13.8.3 SUN? Med-Engineering Perfluorocarbon-based Ultrasound Contrast Agents Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 SUN? Med-Engineering Main Business Overview
13.8.5 SUN? Med-Engineering Latest Developments
13.9 Lizhuo Pharmaceutical
13.9.1 Lizhuo Pharmaceutical Company Information
13.9.2 Lizhuo Pharmaceutical Perfluorocarbon-based Ultrasound Contrast Agents Product Portfolios and Specifications
13.9.3 Lizhuo Pharmaceutical Perfluorocarbon-based Ultrasound Contrast Agents Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Lizhuo Pharmaceutical Main Business Overview
13.9.5 Lizhuo Pharmaceutical Latest Developments
13.10 Fuman Group
13.10.1 Fuman Group Company Information
13.10.2 Fuman Group Perfluorocarbon-based Ultrasound Contrast Agents Product Portfolios and Specifications
13.10.3 Fuman Group Perfluorocarbon-based Ultrasound Contrast Agents Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Fuman Group Main Business Overview
13.10.5 Fuman Group Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Perfluorocarbon-based Ultrasound Contrast Agents Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Perfluorocarbon-based Ultrasound Contrast Agents by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Perfluorocarbon-based Ultrasound Contrast Agents by Country/Region, 2021, 2025 & 2032
2.2 Perfluorocarbon-based Ultrasound Contrast Agents Segment by Type
2.2.1 Sulfur Hexafluoride
2.2.2 Perfluoropropane
2.2.3 Perfluorobutane
2.2.4 Others
2.2.5 Perfluorocarbon-based Ultrasound Contrast Agents Sales by Type
2.2.5.1 Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Market Share by Type (2021-2026)
2.2.5.2 Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue and Market Share by Type (2021-2026)
2.2.5.3 Global Perfluorocarbon-based Ultrasound Contrast Agents Sale Price by Type (2021-2026)
2.3 Perfluorocarbon-based Ultrasound Contrast Agents Segment by Application
2.3.1 Liver Ultrasonography
2.3.2 Angiographic Ultrasonography
2.3.3 Cardiac Ultrasonography
2.3.4 Others
2.3.5 Perfluorocarbon-based Ultrasound Contrast Agents Sales by Application
2.3.5.1 Global Perfluorocarbon-based Ultrasound Contrast Agents Sale Market Share by Application (2021-2026)
2.3.5.2 Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue and Market Share by Application (2021-2026)
2.3.5.3 Global Perfluorocarbon-based Ultrasound Contrast Agents Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Perfluorocarbon-based Ultrasound Contrast Agents Breakdown Data by Company
3.1.1 Global Perfluorocarbon-based Ultrasound Contrast Agents Annual Sales by Company (2021-2026)
3.1.2 Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Market Share by Company (2021-2026)
3.2 Global Perfluorocarbon-based Ultrasound Contrast Agents Annual Revenue by Company (2021-2026)
3.2.1 Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Company (2021-2026)
3.2.2 Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue Market Share by Company (2021-2026)
3.3 Global Perfluorocarbon-based Ultrasound Contrast Agents Sale Price by Company
3.4 Key Manufacturers Perfluorocarbon-based Ultrasound Contrast Agents Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Perfluorocarbon-based Ultrasound Contrast Agents Product Location Distribution
3.4.2 Players Perfluorocarbon-based Ultrasound Contrast Agents Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS BY GEOGRAPHIC REGION
4.1 World Historic Perfluorocarbon-based Ultrasound Contrast Agents Market Size by Geographic Region (2021-2026)
4.1.1 Global Perfluorocarbon-based Ultrasound Contrast Agents Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Perfluorocarbon-based Ultrasound Contrast Agents Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Perfluorocarbon-based Ultrasound Contrast Agents Market Size by Country/Region (2021-2026)
4.2.1 Global Perfluorocarbon-based Ultrasound Contrast Agents Annual Sales by Country/Region (2021-2026)
4.2.2 Global Perfluorocarbon-based Ultrasound Contrast Agents Annual Revenue by Country/Region (2021-2026)
4.3 Americas Perfluorocarbon-based Ultrasound Contrast Agents Sales Growth
4.4 APAC Perfluorocarbon-based Ultrasound Contrast Agents Sales Growth
4.5 Europe Perfluorocarbon-based Ultrasound Contrast Agents Sales Growth
4.6 Middle East & Africa Perfluorocarbon-based Ultrasound Contrast Agents Sales Growth
5 AMERICAS
5.1 Americas Perfluorocarbon-based Ultrasound Contrast Agents Sales by Country
5.1.1 Americas Perfluorocarbon-based Ultrasound Contrast Agents Sales by Country (2021-2026)
5.1.2 Americas Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Country (2021-2026)
5.2 Americas Perfluorocarbon-based Ultrasound Contrast Agents Sales by Type (2021-2026)
5.3 Americas Perfluorocarbon-based Ultrasound Contrast Agents Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Perfluorocarbon-based Ultrasound Contrast Agents Sales by Region
6.1.1 APAC Perfluorocarbon-based Ultrasound Contrast Agents Sales by Region (2021-2026)
6.1.2 APAC Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Region (2021-2026)
6.2 APAC Perfluorocarbon-based Ultrasound Contrast Agents Sales by Type (2021-2026)
6.3 APAC Perfluorocarbon-based Ultrasound Contrast Agents Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Perfluorocarbon-based Ultrasound Contrast Agents by Country
7.1.1 Europe Perfluorocarbon-based Ultrasound Contrast Agents Sales by Country (2021-2026)
7.1.2 Europe Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Country (2021-2026)
7.2 Europe Perfluorocarbon-based Ultrasound Contrast Agents Sales by Type (2021-2026)
7.3 Europe Perfluorocarbon-based Ultrasound Contrast Agents Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Perfluorocarbon-based Ultrasound Contrast Agents by Country
8.1.1 Middle East & Africa Perfluorocarbon-based Ultrasound Contrast Agents Sales by Country (2021-2026)
8.1.2 Middle East & Africa Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Country (2021-2026)
8.2 Middle East & Africa Perfluorocarbon-based Ultrasound Contrast Agents Sales by Type (2021-2026)
8.3 Middle East & Africa Perfluorocarbon-based Ultrasound Contrast Agents Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Perfluorocarbon-based Ultrasound Contrast Agents
10.3 Manufacturing Process Analysis of Perfluorocarbon-based Ultrasound Contrast Agents
10.4 Industry Chain Structure of Perfluorocarbon-based Ultrasound Contrast Agents
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Perfluorocarbon-based Ultrasound Contrast Agents Distributors
11.3 Perfluorocarbon-based Ultrasound Contrast Agents Customer
12 WORLD FORECAST REVIEW FOR PERFLUOROCARBON-BASED ULTRASOUND CONTRAST AGENTS BY GEOGRAPHIC REGION
12.1 Global Perfluorocarbon-based Ultrasound Contrast Agents Market Size Forecast by Region
12.1.1 Global Perfluorocarbon-based Ultrasound Contrast Agents Forecast by Region (2027-2032)
12.1.2 Global Perfluorocarbon-based Ultrasound Contrast Agents Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Perfluorocarbon-based Ultrasound Contrast Agents Forecast by Type (2027-2032)
12.7 Global Perfluorocarbon-based Ultrasound Contrast Agents Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Bracco
13.1.1 Bracco Company Information
13.1.2 Bracco Perfluorocarbon-based Ultrasound Contrast Agents Product Portfolios and Specifications
13.1.3 Bracco Perfluorocarbon-based Ultrasound Contrast Agents Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Bracco Main Business Overview
13.1.5 Bracco Latest Developments
13.2 GE Healthcare
13.2.1 GE Healthcare Company Information
13.2.2 GE Healthcare Perfluorocarbon-based Ultrasound Contrast Agents Product Portfolios and Specifications
13.2.3 GE Healthcare Perfluorocarbon-based Ultrasound Contrast Agents Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 GE Healthcare Main Business Overview
13.2.5 GE Healthcare Latest Developments
13.3 Lantheus Medical Imaging
13.3.1 Lantheus Medical Imaging Company Information
13.3.2 Lantheus Medical Imaging Perfluorocarbon-based Ultrasound Contrast Agents Product Portfolios and Specifications
13.3.3 Lantheus Medical Imaging Perfluorocarbon-based Ultrasound Contrast Agents Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Lantheus Medical Imaging Main Business Overview
13.3.5 Lantheus Medical Imaging Latest Developments
13.4 ImaRx Therapeutics
13.4.1 ImaRx Therapeutics Company Information
13.4.2 ImaRx Therapeutics Perfluorocarbon-based Ultrasound Contrast Agents Product Portfolios and Specifications
13.4.3 ImaRx Therapeutics Perfluorocarbon-based Ultrasound Contrast Agents Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 ImaRx Therapeutics Main Business Overview
13.4.5 ImaRx Therapeutics Latest Developments
13.5 Microvascular Therapeutics
13.5.1 Microvascular Therapeutics Company Information
13.5.2 Microvascular Therapeutics Perfluorocarbon-based Ultrasound Contrast Agents Product Portfolios and Specifications
13.5.3 Microvascular Therapeutics Perfluorocarbon-based Ultrasound Contrast Agents Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Microvascular Therapeutics Main Business Overview
13.5.5 Microvascular Therapeutics Latest Developments
13.6 Qi-hui Biopharmaceutical
13.6.1 Qi-hui Biopharmaceutical Company Information
13.6.2 Qi-hui Biopharmaceutical Perfluorocarbon-based Ultrasound Contrast Agents Product Portfolios and Specifications
13.6.3 Qi-hui Biopharmaceutical Perfluorocarbon-based Ultrasound Contrast Agents Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Qi-hui Biopharmaceutical Main Business Overview
13.6.5 Qi-hui Biopharmaceutical Latest Developments
13.7 Feiruida Medical
13.7.1 Feiruida Medical Company Information
13.7.2 Feiruida Medical Perfluorocarbon-based Ultrasound Contrast Agents Product Portfolios and Specifications
13.7.3 Feiruida Medical Perfluorocarbon-based Ultrasound Contrast Agents Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Feiruida Medical Main Business Overview
13.7.5 Feiruida Medical Latest Developments
13.8 SUN? Med-Engineering
13.8.1 SUN? Med-Engineering Company Information
13.8.2 SUN? Med-Engineering Perfluorocarbon-based Ultrasound Contrast Agents Product Portfolios and Specifications
13.8.3 SUN? Med-Engineering Perfluorocarbon-based Ultrasound Contrast Agents Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 SUN? Med-Engineering Main Business Overview
13.8.5 SUN? Med-Engineering Latest Developments
13.9 Lizhuo Pharmaceutical
13.9.1 Lizhuo Pharmaceutical Company Information
13.9.2 Lizhuo Pharmaceutical Perfluorocarbon-based Ultrasound Contrast Agents Product Portfolios and Specifications
13.9.3 Lizhuo Pharmaceutical Perfluorocarbon-based Ultrasound Contrast Agents Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Lizhuo Pharmaceutical Main Business Overview
13.9.5 Lizhuo Pharmaceutical Latest Developments
13.10 Fuman Group
13.10.1 Fuman Group Company Information
13.10.2 Fuman Group Perfluorocarbon-based Ultrasound Contrast Agents Product Portfolios and Specifications
13.10.3 Fuman Group Perfluorocarbon-based Ultrasound Contrast Agents Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Fuman Group Main Business Overview
13.10.5 Fuman Group Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Perfluorocarbon-based Ultrasound Contrast Agents Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Perfluorocarbon-based Ultrasound Contrast Agents Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Sulfur Hexafluoride
Table 4. Major Players of Perfluoropropane
Table 5. Major Players of Perfluorobutane
Table 6. Major Players of Others
Table 7. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales by Type (2021-2026) & (Units)
Table 8. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Market Share by Type (2021-2026)
Table 9. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Type (2021-2026) & ($ million)
Table 10. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue Market Share by Type (2021-2026)
Table 11. Global Perfluorocarbon-based Ultrasound Contrast Agents Sale Price by Type (2021-2026) & (US$/Unit)
Table 12. Global Perfluorocarbon-based Ultrasound Contrast Agents Sale by Application (2021-2026) & (Units)
Table 13. Global Perfluorocarbon-based Ultrasound Contrast Agents Sale Market Share by Application (2021-2026)
Table 14. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Application (2021-2026) & ($ million)
Table 15. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue Market Share by Application (2021-2026)
Table 16. Global Perfluorocarbon-based Ultrasound Contrast Agents Sale Price by Application (2021-2026) & (US$/Unit)
Table 17. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales by Company (2021-2026) & (Units)
Table 18. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Market Share by Company (2021-2026)
Table 19. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Company (2021-2026) & ($ millions)
Table 20. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue Market Share by Company (2021-2026)
Table 21. Global Perfluorocarbon-based Ultrasound Contrast Agents Sale Price by Company (2021-2026) & (US$/Unit)
Table 22. Key Manufacturers Perfluorocarbon-based Ultrasound Contrast Agents Producing Area Distribution and Sales Area
Table 23. Players Perfluorocarbon-based Ultrasound Contrast Agents Products Offered
Table 24. Perfluorocarbon-based Ultrasound Contrast Agents Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales by Geographic Region (2021-2026) & (Units)
Table 28. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Market Share Geographic Region (2021-2026)
Table 29. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Geographic Region (2021-2026) & ($ millions)
Table 30. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue Market Share by Geographic Region (2021-2026)
Table 31. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales by Country/Region (2021-2026) & (Units)
Table 32. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Market Share by Country/Region (2021-2026)
Table 33. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Country/Region (2021-2026) & ($ millions)
Table 34. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue Market Share by Country/Region (2021-2026)
Table 35. Americas Perfluorocarbon-based Ultrasound Contrast Agents Sales by Country (2021-2026) & (Units)
Table 36. Americas Perfluorocarbon-based Ultrasound Contrast Agents Sales Market Share by Country (2021-2026)
Table 37. Americas Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Country (2021-2026) & ($ millions)
Table 38. Americas Perfluorocarbon-based Ultrasound Contrast Agents Sales by Type (2021-2026) & (Units)
Table 39. Americas Perfluorocarbon-based Ultrasound Contrast Agents Sales by Application (2021-2026) & (Units)
Table 40. APAC Perfluorocarbon-based Ultrasound Contrast Agents Sales by Region (2021-2026) & (Units)
Table 41. APAC Perfluorocarbon-based Ultrasound Contrast Agents Sales Market Share by Region (2021-2026)
Table 42. APAC Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Region (2021-2026) & ($ millions)
Table 43. APAC Perfluorocarbon-based Ultrasound Contrast Agents Sales by Type (2021-2026) & (Units)
Table 44. APAC Perfluorocarbon-based Ultrasound Contrast Agents Sales by Application (2021-2026) & (Units)
Table 45. Europe Perfluorocarbon-based Ultrasound Contrast Agents Sales by Country (2021-2026) & (Units)
Table 46. Europe Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Country (2021-2026) & ($ millions)
Table 47. Europe Perfluorocarbon-based Ultrasound Contrast Agents Sales by Type (2021-2026) & (Units)
Table 48. Europe Perfluorocarbon-based Ultrasound Contrast Agents Sales by Application (2021-2026) & (Units)
Table 49. Middle East & Africa Perfluorocarbon-based Ultrasound Contrast Agents Sales by Country (2021-2026) & (Units)
Table 50. Middle East & Africa Perfluorocarbon-based Ultrasound Contrast Agents Revenue Market Share by Country (2021-2026)
Table 51. Middle East & Africa Perfluorocarbon-based Ultrasound Contrast Agents Sales by Type (2021-2026) & (Units)
Table 52. Middle East & Africa Perfluorocarbon-based Ultrasound Contrast Agents Sales by Application (2021-2026) & (Units)
Table 53. Key Market Drivers & Growth Opportunities of Perfluorocarbon-based Ultrasound Contrast Agents
Table 54. Key Market Challenges & Risks of Perfluorocarbon-based Ultrasound Contrast Agents
Table 55. Key Industry Trends of Perfluorocarbon-based Ultrasound Contrast Agents
Table 56. Perfluorocarbon-based Ultrasound Contrast Agents Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Perfluorocarbon-based Ultrasound Contrast Agents Distributors List
Table 59. Perfluorocarbon-based Ultrasound Contrast Agents Customer List
Table 60. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Forecast by Region (2027-2032) & (Units)
Table 61. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue Forecast by Region (2027-2032) & ($ millions)
Table 62. Americas Perfluorocarbon-based Ultrasound Contrast Agents Sales Forecast by Country (2027-2032) & (Units)
Table 63. Americas Perfluorocarbon-based Ultrasound Contrast Agents Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 64. APAC Perfluorocarbon-based Ultrasound Contrast Agents Sales Forecast by Region (2027-2032) & (Units)
Table 65. APAC Perfluorocarbon-based Ultrasound Contrast Agents Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 66. Europe Perfluorocarbon-based Ultrasound Contrast Agents Sales Forecast by Country (2027-2032) & (Units)
Table 67. Europe Perfluorocarbon-based Ultrasound Contrast Agents Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Middle East & Africa Perfluorocarbon-based Ultrasound Contrast Agents Sales Forecast by Country (2027-2032) & (Units)
Table 69. Middle East & Africa Perfluorocarbon-based Ultrasound Contrast Agents Revenue Forecast by Country (2027-2032) & ($ millions)
Table 70. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Forecast by Type (2027-2032) & (Units)
Table 71. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue Forecast by Type (2027-2032) & ($ millions)
Table 72. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Forecast by Application (2027-2032) & (Units)
Table 73. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue Forecast by Application (2027-2032) & ($ millions)
Table 74. Bracco Basic Information, Perfluorocarbon-based Ultrasound Contrast Agents Manufacturing Base, Sales Area and Its Competitors
Table 75. Bracco Perfluorocarbon-based Ultrasound Contrast Agents Product Portfolios and Specifications
Table 76. Bracco Perfluorocarbon-based Ultrasound Contrast Agents Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 77. Bracco Main Business
Table 78. Bracco Latest Developments
Table 79. GE Healthcare Basic Information, Perfluorocarbon-based Ultrasound Contrast Agents Manufacturing Base, Sales Area and Its Competitors
Table 80. GE Healthcare Perfluorocarbon-based Ultrasound Contrast Agents Product Portfolios and Specifications
Table 81. GE Healthcare Perfluorocarbon-based Ultrasound Contrast Agents Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 82. GE Healthcare Main Business
Table 83. GE Healthcare Latest Developments
Table 84. Lantheus Medical Imaging Basic Information, Perfluorocarbon-based Ultrasound Contrast Agents Manufacturing Base, Sales Area and Its Competitors
Table 85. Lantheus Medical Imaging Perfluorocarbon-based Ultrasound Contrast Agents Product Portfolios and Specifications
Table 86. Lantheus Medical Imaging Perfluorocarbon-based Ultrasound Contrast Agents Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 87. Lantheus Medical Imaging Main Business
Table 88. Lantheus Medical Imaging Latest Developments
Table 89. ImaRx Therapeutics Basic Information, Perfluorocarbon-based Ultrasound Contrast Agents Manufacturing Base, Sales Area and Its Competitors
Table 90. ImaRx Therapeutics Perfluorocarbon-based Ultrasound Contrast Agents Product Portfolios and Specifications
Table 91. ImaRx Therapeutics Perfluorocarbon-based Ultrasound Contrast Agents Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 92. ImaRx Therapeutics Main Business
Table 93. ImaRx Therapeutics Latest Developments
Table 94. Microvascular Therapeutics Basic Information, Perfluorocarbon-based Ultrasound Contrast Agents Manufacturing Base, Sales Area and Its Competitors
Table 95. Microvascular Therapeutics Perfluorocarbon-based Ultrasound Contrast Agents Product Portfolios and Specifications
Table 96. Microvascular Therapeutics Perfluorocarbon-based Ultrasound Contrast Agents Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 97. Microvascular Therapeutics Main Business
Table 98. Microvascular Therapeutics Latest Developments
Table 99. Qi-hui Biopharmaceutical Basic Information, Perfluorocarbon-based Ultrasound Contrast Agents Manufacturing Base, Sales Area and Its Competitors
Table 100. Qi-hui Biopharmaceutical Perfluorocarbon-based Ultrasound Contrast Agents Product Portfolios and Specifications
Table 101. Qi-hui Biopharmaceutical Perfluorocarbon-based Ultrasound Contrast Agents Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 102. Qi-hui Biopharmaceutical Main Business
Table 103. Qi-hui Biopharmaceutical Latest Developments
Table 104. Feiruida Medical Basic Information, Perfluorocarbon-based Ultrasound Contrast Agents Manufacturing Base, Sales Area and Its Competitors
Table 105. Feiruida Medical Perfluorocarbon-based Ultrasound Contrast Agents Product Portfolios and Specifications
Table 106. Feiruida Medical Perfluorocarbon-based Ultrasound Contrast Agents Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 107. Feiruida Medical Main Business
Table 108. Feiruida Medical Latest Developments
Table 109. SUN? Med-Engineering Basic Information, Perfluorocarbon-based Ultrasound Contrast Agents Manufacturing Base, Sales Area and Its Competitors
Table 110. SUN? Med-Engineering Perfluorocarbon-based Ultrasound Contrast Agents Product Portfolios and Specifications
Table 111. SUN? Med-Engineering Perfluorocarbon-based Ultrasound Contrast Agents Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 112. SUN? Med-Engineering Main Business
Table 113. SUN? Med-Engineering Latest Developments
Table 114. Lizhuo Pharmaceutical Basic Information, Perfluorocarbon-based Ultrasound Contrast Agents Manufacturing Base, Sales Area and Its Competitors
Table 115. Lizhuo Pharmaceutical Perfluorocarbon-based Ultrasound Contrast Agents Product Portfolios and Specifications
Table 116. Lizhuo Pharmaceutical Perfluorocarbon-based Ultrasound Contrast Agents Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 117. Lizhuo Pharmaceutical Main Business
Table 118. Lizhuo Pharmaceutical Latest Developments
Table 119. Fuman Group Basic Information, Perfluorocarbon-based Ultrasound Contrast Agents Manufacturing Base, Sales Area and Its Competitors
Table 120. Fuman Group Perfluorocarbon-based Ultrasound Contrast Agents Product Portfolios and Specifications
Table 121. Fuman Group Perfluorocarbon-based Ultrasound Contrast Agents Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 122. Fuman Group Main Business
Table 123. Fuman Group Latest Developments
Table 1. Perfluorocarbon-based Ultrasound Contrast Agents Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Perfluorocarbon-based Ultrasound Contrast Agents Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Sulfur Hexafluoride
Table 4. Major Players of Perfluoropropane
Table 5. Major Players of Perfluorobutane
Table 6. Major Players of Others
Table 7. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales by Type (2021-2026) & (Units)
Table 8. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Market Share by Type (2021-2026)
Table 9. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Type (2021-2026) & ($ million)
Table 10. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue Market Share by Type (2021-2026)
Table 11. Global Perfluorocarbon-based Ultrasound Contrast Agents Sale Price by Type (2021-2026) & (US$/Unit)
Table 12. Global Perfluorocarbon-based Ultrasound Contrast Agents Sale by Application (2021-2026) & (Units)
Table 13. Global Perfluorocarbon-based Ultrasound Contrast Agents Sale Market Share by Application (2021-2026)
Table 14. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Application (2021-2026) & ($ million)
Table 15. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue Market Share by Application (2021-2026)
Table 16. Global Perfluorocarbon-based Ultrasound Contrast Agents Sale Price by Application (2021-2026) & (US$/Unit)
Table 17. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales by Company (2021-2026) & (Units)
Table 18. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Market Share by Company (2021-2026)
Table 19. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Company (2021-2026) & ($ millions)
Table 20. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue Market Share by Company (2021-2026)
Table 21. Global Perfluorocarbon-based Ultrasound Contrast Agents Sale Price by Company (2021-2026) & (US$/Unit)
Table 22. Key Manufacturers Perfluorocarbon-based Ultrasound Contrast Agents Producing Area Distribution and Sales Area
Table 23. Players Perfluorocarbon-based Ultrasound Contrast Agents Products Offered
Table 24. Perfluorocarbon-based Ultrasound Contrast Agents Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales by Geographic Region (2021-2026) & (Units)
Table 28. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Market Share Geographic Region (2021-2026)
Table 29. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Geographic Region (2021-2026) & ($ millions)
Table 30. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue Market Share by Geographic Region (2021-2026)
Table 31. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales by Country/Region (2021-2026) & (Units)
Table 32. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Market Share by Country/Region (2021-2026)
Table 33. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Country/Region (2021-2026) & ($ millions)
Table 34. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue Market Share by Country/Region (2021-2026)
Table 35. Americas Perfluorocarbon-based Ultrasound Contrast Agents Sales by Country (2021-2026) & (Units)
Table 36. Americas Perfluorocarbon-based Ultrasound Contrast Agents Sales Market Share by Country (2021-2026)
Table 37. Americas Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Country (2021-2026) & ($ millions)
Table 38. Americas Perfluorocarbon-based Ultrasound Contrast Agents Sales by Type (2021-2026) & (Units)
Table 39. Americas Perfluorocarbon-based Ultrasound Contrast Agents Sales by Application (2021-2026) & (Units)
Table 40. APAC Perfluorocarbon-based Ultrasound Contrast Agents Sales by Region (2021-2026) & (Units)
Table 41. APAC Perfluorocarbon-based Ultrasound Contrast Agents Sales Market Share by Region (2021-2026)
Table 42. APAC Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Region (2021-2026) & ($ millions)
Table 43. APAC Perfluorocarbon-based Ultrasound Contrast Agents Sales by Type (2021-2026) & (Units)
Table 44. APAC Perfluorocarbon-based Ultrasound Contrast Agents Sales by Application (2021-2026) & (Units)
Table 45. Europe Perfluorocarbon-based Ultrasound Contrast Agents Sales by Country (2021-2026) & (Units)
Table 46. Europe Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Country (2021-2026) & ($ millions)
Table 47. Europe Perfluorocarbon-based Ultrasound Contrast Agents Sales by Type (2021-2026) & (Units)
Table 48. Europe Perfluorocarbon-based Ultrasound Contrast Agents Sales by Application (2021-2026) & (Units)
Table 49. Middle East & Africa Perfluorocarbon-based Ultrasound Contrast Agents Sales by Country (2021-2026) & (Units)
Table 50. Middle East & Africa Perfluorocarbon-based Ultrasound Contrast Agents Revenue Market Share by Country (2021-2026)
Table 51. Middle East & Africa Perfluorocarbon-based Ultrasound Contrast Agents Sales by Type (2021-2026) & (Units)
Table 52. Middle East & Africa Perfluorocarbon-based Ultrasound Contrast Agents Sales by Application (2021-2026) & (Units)
Table 53. Key Market Drivers & Growth Opportunities of Perfluorocarbon-based Ultrasound Contrast Agents
Table 54. Key Market Challenges & Risks of Perfluorocarbon-based Ultrasound Contrast Agents
Table 55. Key Industry Trends of Perfluorocarbon-based Ultrasound Contrast Agents
Table 56. Perfluorocarbon-based Ultrasound Contrast Agents Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Perfluorocarbon-based Ultrasound Contrast Agents Distributors List
Table 59. Perfluorocarbon-based Ultrasound Contrast Agents Customer List
Table 60. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Forecast by Region (2027-2032) & (Units)
Table 61. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue Forecast by Region (2027-2032) & ($ millions)
Table 62. Americas Perfluorocarbon-based Ultrasound Contrast Agents Sales Forecast by Country (2027-2032) & (Units)
Table 63. Americas Perfluorocarbon-based Ultrasound Contrast Agents Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 64. APAC Perfluorocarbon-based Ultrasound Contrast Agents Sales Forecast by Region (2027-2032) & (Units)
Table 65. APAC Perfluorocarbon-based Ultrasound Contrast Agents Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 66. Europe Perfluorocarbon-based Ultrasound Contrast Agents Sales Forecast by Country (2027-2032) & (Units)
Table 67. Europe Perfluorocarbon-based Ultrasound Contrast Agents Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Middle East & Africa Perfluorocarbon-based Ultrasound Contrast Agents Sales Forecast by Country (2027-2032) & (Units)
Table 69. Middle East & Africa Perfluorocarbon-based Ultrasound Contrast Agents Revenue Forecast by Country (2027-2032) & ($ millions)
Table 70. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Forecast by Type (2027-2032) & (Units)
Table 71. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue Forecast by Type (2027-2032) & ($ millions)
Table 72. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Forecast by Application (2027-2032) & (Units)
Table 73. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue Forecast by Application (2027-2032) & ($ millions)
Table 74. Bracco Basic Information, Perfluorocarbon-based Ultrasound Contrast Agents Manufacturing Base, Sales Area and Its Competitors
Table 75. Bracco Perfluorocarbon-based Ultrasound Contrast Agents Product Portfolios and Specifications
Table 76. Bracco Perfluorocarbon-based Ultrasound Contrast Agents Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 77. Bracco Main Business
Table 78. Bracco Latest Developments
Table 79. GE Healthcare Basic Information, Perfluorocarbon-based Ultrasound Contrast Agents Manufacturing Base, Sales Area and Its Competitors
Table 80. GE Healthcare Perfluorocarbon-based Ultrasound Contrast Agents Product Portfolios and Specifications
Table 81. GE Healthcare Perfluorocarbon-based Ultrasound Contrast Agents Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 82. GE Healthcare Main Business
Table 83. GE Healthcare Latest Developments
Table 84. Lantheus Medical Imaging Basic Information, Perfluorocarbon-based Ultrasound Contrast Agents Manufacturing Base, Sales Area and Its Competitors
Table 85. Lantheus Medical Imaging Perfluorocarbon-based Ultrasound Contrast Agents Product Portfolios and Specifications
Table 86. Lantheus Medical Imaging Perfluorocarbon-based Ultrasound Contrast Agents Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 87. Lantheus Medical Imaging Main Business
Table 88. Lantheus Medical Imaging Latest Developments
Table 89. ImaRx Therapeutics Basic Information, Perfluorocarbon-based Ultrasound Contrast Agents Manufacturing Base, Sales Area and Its Competitors
Table 90. ImaRx Therapeutics Perfluorocarbon-based Ultrasound Contrast Agents Product Portfolios and Specifications
Table 91. ImaRx Therapeutics Perfluorocarbon-based Ultrasound Contrast Agents Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 92. ImaRx Therapeutics Main Business
Table 93. ImaRx Therapeutics Latest Developments
Table 94. Microvascular Therapeutics Basic Information, Perfluorocarbon-based Ultrasound Contrast Agents Manufacturing Base, Sales Area and Its Competitors
Table 95. Microvascular Therapeutics Perfluorocarbon-based Ultrasound Contrast Agents Product Portfolios and Specifications
Table 96. Microvascular Therapeutics Perfluorocarbon-based Ultrasound Contrast Agents Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 97. Microvascular Therapeutics Main Business
Table 98. Microvascular Therapeutics Latest Developments
Table 99. Qi-hui Biopharmaceutical Basic Information, Perfluorocarbon-based Ultrasound Contrast Agents Manufacturing Base, Sales Area and Its Competitors
Table 100. Qi-hui Biopharmaceutical Perfluorocarbon-based Ultrasound Contrast Agents Product Portfolios and Specifications
Table 101. Qi-hui Biopharmaceutical Perfluorocarbon-based Ultrasound Contrast Agents Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 102. Qi-hui Biopharmaceutical Main Business
Table 103. Qi-hui Biopharmaceutical Latest Developments
Table 104. Feiruida Medical Basic Information, Perfluorocarbon-based Ultrasound Contrast Agents Manufacturing Base, Sales Area and Its Competitors
Table 105. Feiruida Medical Perfluorocarbon-based Ultrasound Contrast Agents Product Portfolios and Specifications
Table 106. Feiruida Medical Perfluorocarbon-based Ultrasound Contrast Agents Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 107. Feiruida Medical Main Business
Table 108. Feiruida Medical Latest Developments
Table 109. SUN? Med-Engineering Basic Information, Perfluorocarbon-based Ultrasound Contrast Agents Manufacturing Base, Sales Area and Its Competitors
Table 110. SUN? Med-Engineering Perfluorocarbon-based Ultrasound Contrast Agents Product Portfolios and Specifications
Table 111. SUN? Med-Engineering Perfluorocarbon-based Ultrasound Contrast Agents Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 112. SUN? Med-Engineering Main Business
Table 113. SUN? Med-Engineering Latest Developments
Table 114. Lizhuo Pharmaceutical Basic Information, Perfluorocarbon-based Ultrasound Contrast Agents Manufacturing Base, Sales Area and Its Competitors
Table 115. Lizhuo Pharmaceutical Perfluorocarbon-based Ultrasound Contrast Agents Product Portfolios and Specifications
Table 116. Lizhuo Pharmaceutical Perfluorocarbon-based Ultrasound Contrast Agents Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 117. Lizhuo Pharmaceutical Main Business
Table 118. Lizhuo Pharmaceutical Latest Developments
Table 119. Fuman Group Basic Information, Perfluorocarbon-based Ultrasound Contrast Agents Manufacturing Base, Sales Area and Its Competitors
Table 120. Fuman Group Perfluorocarbon-based Ultrasound Contrast Agents Product Portfolios and Specifications
Table 121. Fuman Group Perfluorocarbon-based Ultrasound Contrast Agents Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 122. Fuman Group Main Business
Table 123. Fuman Group Latest Developments
LIST OF FIGURES
Figure 1. Picture of Perfluorocarbon-based Ultrasound Contrast Agents
Figure 2. Perfluorocarbon-based Ultrasound Contrast Agents Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Growth Rate 2021-2032 (Units)
Figure 7. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Perfluorocarbon-based Ultrasound Contrast Agents Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Perfluorocarbon-based Ultrasound Contrast Agents Sales Market Share by Country/Region (2025)
Figure 10. Perfluorocarbon-based Ultrasound Contrast Agents Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Sulfur Hexafluoride
Figure 12. Product Picture of Perfluoropropane
Figure 13. Product Picture of Perfluorobutane
Figure 14. Product Picture of Others
Figure 15. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Market Share by Type in 2026
Figure 16. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue Market Share by Type (2021-2026)
Figure 17. Perfluorocarbon-based Ultrasound Contrast Agents Consumed in Liver Ultrasonography
Figure 18. Global Perfluorocarbon-based Ultrasound Contrast Agents Market: Liver Ultrasonography (2021-2026) & (Units)
Figure 19. Perfluorocarbon-based Ultrasound Contrast Agents Consumed in Angiographic Ultrasonography
Figure 20. Global Perfluorocarbon-based Ultrasound Contrast Agents Market: Angiographic Ultrasonography (2021-2026) & (Units)
Figure 21. Perfluorocarbon-based Ultrasound Contrast Agents Consumed in Cardiac Ultrasonography
Figure 22. Global Perfluorocarbon-based Ultrasound Contrast Agents Market: Cardiac Ultrasonography (2021-2026) & (Units)
Figure 23. Perfluorocarbon-based Ultrasound Contrast Agents Consumed in Others
Figure 24. Global Perfluorocarbon-based Ultrasound Contrast Agents Market: Others (2021-2026) & (Units)
Figure 25. Global Perfluorocarbon-based Ultrasound Contrast Agents Sale Market Share by Application (2025)
Figure 26. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue Market Share by Application in 2026
Figure 27. Perfluorocarbon-based Ultrasound Contrast Agents Sales by Company in 2026 (Units)
Figure 28. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Market Share by Company in 2026
Figure 29. Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Company in 2026 ($ millions)
Figure 30. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue Market Share by Company in 2026
Figure 31. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Market Share by Geographic Region (2021-2026)
Figure 32. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue Market Share by Geographic Region in 2026
Figure 33. Americas Perfluorocarbon-based Ultrasound Contrast Agents Sales 2021-2026 (Units)
Figure 34. Americas Perfluorocarbon-based Ultrasound Contrast Agents Revenue 2021-2026 ($ millions)
Figure 35. APAC Perfluorocarbon-based Ultrasound Contrast Agents Sales 2021-2026 (Units)
Figure 36. APAC Perfluorocarbon-based Ultrasound Contrast Agents Revenue 2021-2026 ($ millions)
Figure 37. Europe Perfluorocarbon-based Ultrasound Contrast Agents Sales 2021-2026 (Units)
Figure 38. Europe Perfluorocarbon-based Ultrasound Contrast Agents Revenue 2021-2026 ($ millions)
Figure 39. Middle East & Africa Perfluorocarbon-based Ultrasound Contrast Agents Sales 2021-2026 (Units)
Figure 40. Middle East & Africa Perfluorocarbon-based Ultrasound Contrast Agents Revenue 2021-2026 ($ millions)
Figure 41. Americas Perfluorocarbon-based Ultrasound Contrast Agents Sales Market Share by Country in 2026
Figure 42. Americas Perfluorocarbon-based Ultrasound Contrast Agents Revenue Market Share by Country (2021-2026)
Figure 43. Americas Perfluorocarbon-based Ultrasound Contrast Agents Sales Market Share by Type (2021-2026)
Figure 44. Americas Perfluorocarbon-based Ultrasound Contrast Agents Sales Market Share by Application (2021-2026)
Figure 45. United States Perfluorocarbon-based Ultrasound Contrast Agents Revenue Growth 2021-2026 ($ millions)
Figure 46. Canada Perfluorocarbon-based Ultrasound Contrast Agents Revenue Growth 2021-2026 ($ millions)
Figure 47. Mexico Perfluorocarbon-based Ultrasound Contrast Agents Revenue Growth 2021-2026 ($ millions)
Figure 48. Brazil Perfluorocarbon-based Ultrasound Contrast Agents Revenue Growth 2021-2026 ($ millions)
Figure 49. APAC Perfluorocarbon-based Ultrasound Contrast Agents Sales Market Share by Region in 2026
Figure 50. APAC Perfluorocarbon-based Ultrasound Contrast Agents Revenue Market Share by Region (2021-2026)
Figure 51. APAC Perfluorocarbon-based Ultrasound Contrast Agents Sales Market Share by Type (2021-2026)
Figure 52. APAC Perfluorocarbon-based Ultrasound Contrast Agents Sales Market Share by Application (2021-2026)
Figure 53. China Perfluorocarbon-based Ultrasound Contrast Agents Revenue Growth 2021-2026 ($ millions)
Figure 54. Japan Perfluorocarbon-based Ultrasound Contrast Agents Revenue Growth 2021-2026 ($ millions)
Figure 55. South Korea Perfluorocarbon-based Ultrasound Contrast Agents Revenue Growth 2021-2026 ($ millions)
Figure 56. Southeast Asia Perfluorocarbon-based Ultrasound Contrast Agents Revenue Growth 2021-2026 ($ millions)
Figure 57. India Perfluorocarbon-based Ultrasound Contrast Agents Revenue Growth 2021-2026 ($ millions)
Figure 58. Australia Perfluorocarbon-based Ultrasound Contrast Agents Revenue Growth 2021-2026 ($ millions)
Figure 59. China Taiwan Perfluorocarbon-based Ultrasound Contrast Agents Revenue Growth 2021-2026 ($ millions)
Figure 60. Europe Perfluorocarbon-based Ultrasound Contrast Agents Sales Market Share by Country in 2026
Figure 61. Europe Perfluorocarbon-based Ultrasound Contrast Agents Revenue Market Share by Country (2021-2026)
Figure 62. Europe Perfluorocarbon-based Ultrasound Contrast Agents Sales Market Share by Type (2021-2026)
Figure 63. Europe Perfluorocarbon-based Ultrasound Contrast Agents Sales Market Share by Application (2021-2026)
Figure 64. Germany Perfluorocarbon-based Ultrasound Contrast Agents Revenue Growth 2021-2026 ($ millions)
Figure 65. France Perfluorocarbon-based Ultrasound Contrast Agents Revenue Growth 2021-2026 ($ millions)
Figure 66. UK Perfluorocarbon-based Ultrasound Contrast Agents Revenue Growth 2021-2026 ($ millions)
Figure 67. Italy Perfluorocarbon-based Ultrasound Contrast Agents Revenue Growth 2021-2026 ($ millions)
Figure 68. Russia Perfluorocarbon-based Ultrasound Contrast Agents Revenue Growth 2021-2026 ($ millions)
Figure 69. Middle East & Africa Perfluorocarbon-based Ultrasound Contrast Agents Sales Market Share by Country (2021-2026)
Figure 70. Middle East & Africa Perfluorocarbon-based Ultrasound Contrast Agents Sales Market Share by Type (2021-2026)
Figure 71. Middle East & Africa Perfluorocarbon-based Ultrasound Contrast Agents Sales Market Share by Application (2021-2026)
Figure 72. Egypt Perfluorocarbon-based Ultrasound Contrast Agents Revenue Growth 2021-2026 ($ millions)
Figure 73. South Africa Perfluorocarbon-based Ultrasound Contrast Agents Revenue Growth 2021-2026 ($ millions)
Figure 74. Israel Perfluorocarbon-based Ultrasound Contrast Agents Revenue Growth 2021-2026 ($ millions)
Figure 75. Turkey Perfluorocarbon-based Ultrasound Contrast Agents Revenue Growth 2021-2026 ($ millions)
Figure 76. GCC Countries Perfluorocarbon-based Ultrasound Contrast Agents Revenue Growth 2021-2026 ($ millions)
Figure 77. Manufacturing Cost Structure Analysis of Perfluorocarbon-based Ultrasound Contrast Agents in 2026
Figure 78. Manufacturing Process Analysis of Perfluorocarbon-based Ultrasound Contrast Agents
Figure 79. Industry Chain Structure of Perfluorocarbon-based Ultrasound Contrast Agents
Figure 80. Channels of Distribution
Figure 81. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Market Forecast by Region (2027-2032)
Figure 82. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue Market Share Forecast by Region (2027-2032)
Figure 83. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Market Share Forecast by Type (2027-2032)
Figure 84. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue Market Share Forecast by Type (2027-2032)
Figure 85. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Market Share Forecast by Application (2027-2032)
Figure 86. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Perfluorocarbon-based Ultrasound Contrast Agents
Figure 2. Perfluorocarbon-based Ultrasound Contrast Agents Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Growth Rate 2021-2032 (Units)
Figure 7. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Perfluorocarbon-based Ultrasound Contrast Agents Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Perfluorocarbon-based Ultrasound Contrast Agents Sales Market Share by Country/Region (2025)
Figure 10. Perfluorocarbon-based Ultrasound Contrast Agents Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Sulfur Hexafluoride
Figure 12. Product Picture of Perfluoropropane
Figure 13. Product Picture of Perfluorobutane
Figure 14. Product Picture of Others
Figure 15. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Market Share by Type in 2026
Figure 16. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue Market Share by Type (2021-2026)
Figure 17. Perfluorocarbon-based Ultrasound Contrast Agents Consumed in Liver Ultrasonography
Figure 18. Global Perfluorocarbon-based Ultrasound Contrast Agents Market: Liver Ultrasonography (2021-2026) & (Units)
Figure 19. Perfluorocarbon-based Ultrasound Contrast Agents Consumed in Angiographic Ultrasonography
Figure 20. Global Perfluorocarbon-based Ultrasound Contrast Agents Market: Angiographic Ultrasonography (2021-2026) & (Units)
Figure 21. Perfluorocarbon-based Ultrasound Contrast Agents Consumed in Cardiac Ultrasonography
Figure 22. Global Perfluorocarbon-based Ultrasound Contrast Agents Market: Cardiac Ultrasonography (2021-2026) & (Units)
Figure 23. Perfluorocarbon-based Ultrasound Contrast Agents Consumed in Others
Figure 24. Global Perfluorocarbon-based Ultrasound Contrast Agents Market: Others (2021-2026) & (Units)
Figure 25. Global Perfluorocarbon-based Ultrasound Contrast Agents Sale Market Share by Application (2025)
Figure 26. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue Market Share by Application in 2026
Figure 27. Perfluorocarbon-based Ultrasound Contrast Agents Sales by Company in 2026 (Units)
Figure 28. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Market Share by Company in 2026
Figure 29. Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Company in 2026 ($ millions)
Figure 30. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue Market Share by Company in 2026
Figure 31. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Market Share by Geographic Region (2021-2026)
Figure 32. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue Market Share by Geographic Region in 2026
Figure 33. Americas Perfluorocarbon-based Ultrasound Contrast Agents Sales 2021-2026 (Units)
Figure 34. Americas Perfluorocarbon-based Ultrasound Contrast Agents Revenue 2021-2026 ($ millions)
Figure 35. APAC Perfluorocarbon-based Ultrasound Contrast Agents Sales 2021-2026 (Units)
Figure 36. APAC Perfluorocarbon-based Ultrasound Contrast Agents Revenue 2021-2026 ($ millions)
Figure 37. Europe Perfluorocarbon-based Ultrasound Contrast Agents Sales 2021-2026 (Units)
Figure 38. Europe Perfluorocarbon-based Ultrasound Contrast Agents Revenue 2021-2026 ($ millions)
Figure 39. Middle East & Africa Perfluorocarbon-based Ultrasound Contrast Agents Sales 2021-2026 (Units)
Figure 40. Middle East & Africa Perfluorocarbon-based Ultrasound Contrast Agents Revenue 2021-2026 ($ millions)
Figure 41. Americas Perfluorocarbon-based Ultrasound Contrast Agents Sales Market Share by Country in 2026
Figure 42. Americas Perfluorocarbon-based Ultrasound Contrast Agents Revenue Market Share by Country (2021-2026)
Figure 43. Americas Perfluorocarbon-based Ultrasound Contrast Agents Sales Market Share by Type (2021-2026)
Figure 44. Americas Perfluorocarbon-based Ultrasound Contrast Agents Sales Market Share by Application (2021-2026)
Figure 45. United States Perfluorocarbon-based Ultrasound Contrast Agents Revenue Growth 2021-2026 ($ millions)
Figure 46. Canada Perfluorocarbon-based Ultrasound Contrast Agents Revenue Growth 2021-2026 ($ millions)
Figure 47. Mexico Perfluorocarbon-based Ultrasound Contrast Agents Revenue Growth 2021-2026 ($ millions)
Figure 48. Brazil Perfluorocarbon-based Ultrasound Contrast Agents Revenue Growth 2021-2026 ($ millions)
Figure 49. APAC Perfluorocarbon-based Ultrasound Contrast Agents Sales Market Share by Region in 2026
Figure 50. APAC Perfluorocarbon-based Ultrasound Contrast Agents Revenue Market Share by Region (2021-2026)
Figure 51. APAC Perfluorocarbon-based Ultrasound Contrast Agents Sales Market Share by Type (2021-2026)
Figure 52. APAC Perfluorocarbon-based Ultrasound Contrast Agents Sales Market Share by Application (2021-2026)
Figure 53. China Perfluorocarbon-based Ultrasound Contrast Agents Revenue Growth 2021-2026 ($ millions)
Figure 54. Japan Perfluorocarbon-based Ultrasound Contrast Agents Revenue Growth 2021-2026 ($ millions)
Figure 55. South Korea Perfluorocarbon-based Ultrasound Contrast Agents Revenue Growth 2021-2026 ($ millions)
Figure 56. Southeast Asia Perfluorocarbon-based Ultrasound Contrast Agents Revenue Growth 2021-2026 ($ millions)
Figure 57. India Perfluorocarbon-based Ultrasound Contrast Agents Revenue Growth 2021-2026 ($ millions)
Figure 58. Australia Perfluorocarbon-based Ultrasound Contrast Agents Revenue Growth 2021-2026 ($ millions)
Figure 59. China Taiwan Perfluorocarbon-based Ultrasound Contrast Agents Revenue Growth 2021-2026 ($ millions)
Figure 60. Europe Perfluorocarbon-based Ultrasound Contrast Agents Sales Market Share by Country in 2026
Figure 61. Europe Perfluorocarbon-based Ultrasound Contrast Agents Revenue Market Share by Country (2021-2026)
Figure 62. Europe Perfluorocarbon-based Ultrasound Contrast Agents Sales Market Share by Type (2021-2026)
Figure 63. Europe Perfluorocarbon-based Ultrasound Contrast Agents Sales Market Share by Application (2021-2026)
Figure 64. Germany Perfluorocarbon-based Ultrasound Contrast Agents Revenue Growth 2021-2026 ($ millions)
Figure 65. France Perfluorocarbon-based Ultrasound Contrast Agents Revenue Growth 2021-2026 ($ millions)
Figure 66. UK Perfluorocarbon-based Ultrasound Contrast Agents Revenue Growth 2021-2026 ($ millions)
Figure 67. Italy Perfluorocarbon-based Ultrasound Contrast Agents Revenue Growth 2021-2026 ($ millions)
Figure 68. Russia Perfluorocarbon-based Ultrasound Contrast Agents Revenue Growth 2021-2026 ($ millions)
Figure 69. Middle East & Africa Perfluorocarbon-based Ultrasound Contrast Agents Sales Market Share by Country (2021-2026)
Figure 70. Middle East & Africa Perfluorocarbon-based Ultrasound Contrast Agents Sales Market Share by Type (2021-2026)
Figure 71. Middle East & Africa Perfluorocarbon-based Ultrasound Contrast Agents Sales Market Share by Application (2021-2026)
Figure 72. Egypt Perfluorocarbon-based Ultrasound Contrast Agents Revenue Growth 2021-2026 ($ millions)
Figure 73. South Africa Perfluorocarbon-based Ultrasound Contrast Agents Revenue Growth 2021-2026 ($ millions)
Figure 74. Israel Perfluorocarbon-based Ultrasound Contrast Agents Revenue Growth 2021-2026 ($ millions)
Figure 75. Turkey Perfluorocarbon-based Ultrasound Contrast Agents Revenue Growth 2021-2026 ($ millions)
Figure 76. GCC Countries Perfluorocarbon-based Ultrasound Contrast Agents Revenue Growth 2021-2026 ($ millions)
Figure 77. Manufacturing Cost Structure Analysis of Perfluorocarbon-based Ultrasound Contrast Agents in 2026
Figure 78. Manufacturing Process Analysis of Perfluorocarbon-based Ultrasound Contrast Agents
Figure 79. Industry Chain Structure of Perfluorocarbon-based Ultrasound Contrast Agents
Figure 80. Channels of Distribution
Figure 81. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Market Forecast by Region (2027-2032)
Figure 82. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue Market Share Forecast by Region (2027-2032)
Figure 83. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Market Share Forecast by Type (2027-2032)
Figure 84. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue Market Share Forecast by Type (2027-2032)
Figure 85. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Market Share Forecast by Application (2027-2032)
Figure 86. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue Market Share Forecast by Application (2027-2032)
